ARDSLEY, N.Y.--(BUSINESS WIRE)--Acorda Therapeutics, Inc. (Nasdaq:ACOR) today announced that the U.S. Food and Drug Administration approved INBRIJA™ for intermittent treatment of OFF episodes in ...
(HealthDay News) — Animal studies have uncovered a compound that might reduce the adverse effects of levodopa. The research was published in the Nov. 18 issue of Neuron. In the new study, an ...
About one million people in the United States are living with Parkinson’s Disease. Levodopa is the most effective drug available, but the drug can cause side effects, and after several years, the ...
The US Food and Drug Administration (FDA) has approved an extended-release capsule formulation of carbidopa-levodopa (Rytary, IPX066, Impax Pharmaceuticals) for the treatment of Parkinson's disease ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback